NeurologyLive® Brain Games: February 19, 2023

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is stroke and cerebrovascular disease.

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

This week's questions have the theme of stroke and cerebrovascular disease.

Click here to check out the prior iterations of Brain Games.

Interested in submitting quiz questions? Contact our associate editorial director, Matt Hoffman, via email: mhoffman@neurologylive.com.

The FDA cleared the MERCI retriever as the first device to be used for clot removal in acute ischemic stroke, somewhat controversially, in August of what year?


Globally, there are more than 12 million new strokes each year. What percent of all strokes occur among those aged 15-49 years?


The first successful ligation of the carotid for an aneurysm in the United States was performed by Dr. Wright Post on January 9 of what year?


How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!

How many questions did you get correct?

One
Two
Three
Related Videos
Diana Castro, MD
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
Amaal Starling, MD, FAHS, FAAN
Lars Alfredsson, PhD
Ava Easton, PhD
Jenn Orthmann-Murphy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.